Print（PDF/136KB） Jun. 30, 2023 Corporate

Sumitomo Pharma Announces Changes in Executive Officers

Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomura) today announced the following changes in Executive Officers.

(1) New Executive Officers (effective July 1, 2023)

Myrtle Potter	(currently CEO, Sumitovant Biopharma, Inc.)
Adele Gulfo	(currently Chief Business Development and Commercialization Officer, Sumitovant Biopharma, Inc.)
Armin Szegedi	(currently Senior Vice President and Chief Medical Officer, Sunovion Pharmaceuticals Inc.)

(2) Retiring Executive Officers (effective June 30, 2023)

Antony Loebel	(currently Executive Officer, President and CEO, Sunovion Pharmaceuticals Inc.)
Patricia S. Andrews	(currently Executive Officer, CEO, Sumitomo Pharma Oncology, Inc., Global Head of Oncology)